Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OROS Hydromorphone in Osteoarthritis Pain
NCT00980798Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2007
- Primary completion
- Nov 2008
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 3 trial of hydromorphone in osteoarthritis (OA), sponsored by Janssen Pharmaceutical. Started Oct 2007; status: completed.
02
Drugs
hydromorphone
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00980798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00980798.